Target intelligence / Profile preview

Transmembrane protein 120A (TMEM120A)

Target
TMEM120A
Molecular classification
Transmembrane protein, Coenzyme A-binding membrane protein, Putative enzyme (similarity to ELOVL elongase family), Putative ion channel (proposed, disputed), Other
01

Overview

Transmembrane protein 120A (TMEM120A) is a membrane protein that forms a homodimer and binds coenzyme A (CoA) in a deep intracellular cavity[1][2][4]. TMEM120A is highly conserved, with structural similarity to membrane-embedded enzymes of the ELOVL family, implicating a possible but unconfirmed enzymatic role in fatty acid metabolism[3][4]. It is crucial for adipocyte differentiation and systemic metabolism, as knockout in mice leads to lipodystrophy syndrome with insulin resistance[1][4]. TMEM120A was proposed to function as a mechanosensitive ion channel involved in mechanical pain, but structural and functional analyses have failed to confirm inherent channel activity or canonical ion channel architecture, and its role in mechanosensation remains controversial[1][4][5]. The significance of its interaction with CoA remains under investigation but may relate to roles in fatty acid metabolism, CoA sensing, or transport[1][2][4]. TMEM120A is sometimes referred to as TACAN in pain-sensing literature, but its predominant, well-established function lies in lipid biology and metabolism[1][4]. **Key points:** - *Transmembrane protein 120A* is the canonical name; *TMEM120A* is the established abbreviation. - TMEM120A is a validated molecular target based on its biological and disease relevance, though no approved drugs are known to act directly on it. - Its mechanistic and therapeutic classification is evolving, with strongest consensus on roles in metabolism, and limited, disputed evidence for ion channel or nociceptor function.

Other names
TACANTMPITNET29Protein TACANTransmembrane protein induced by tumor necrosis factor alphaion channel TACAN
02

Biological functions

Adipocyte differentiationLipid metabolismCoenzyme A bindingPossible modulation of mechanosensation (disputed)
03

Disease associations

Metabolic diseases (e.g., lipodystrophy, insulin resistance)Potential pain modulation/neuropathic pain (disputed)Other
04

Safety considerations

Potential metabolic effects (lipodystrophy, fat metabolism disturbances with gene disruption in mice)Potential neuronal effects if truly involved in pain sensation (unconfirmed)
05

Biomarkers

Potential marker for adipocyte differentiation and metabolic states

Beyond the preview

Go deeper on Transmembrane protein 120A (TMEM120A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 120A (TMEM120A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call